Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

[Enhancing effect of compound Kusheng injection in combination with chemotherapy for patients with advanced non-small cell lung cancer].

Fan CX, Lin CL, Liang L, Zhao YY, Liu J, Cui J, Yang QM, Wang YL, Zhang AR.

Zhonghua Zhong Liu Za Zhi. 2010 Apr;32(4):294-7. Chinese.

PMID:
20510083
2.

Treatment of advanced non-small-cell lung cancer with Chinese herbal medicine by stages combined with chemotherapy.

Xu ZY, Jin CJ, Zhou CC, Wang ZQ, Zhou WD, Deng HB, Zhang M, Su W, Cai XY.

J Cancer Res Clin Oncol. 2011 Jul;137(7):1117-22. doi: 10.1007/s00432-011-0975-3. Epub 2011 Feb 5.

PMID:
21298288
3.

[Prognostic analysis of stage III-IV non-small cell lung cancer patients treated by traditional chinese medicine].

Zhou DH, Lin LZ, Zhou YQ, Luo RC, Liu KF, Jia YJ, Chen JY, Niu XW, Su BR, Lu J, Wang ST.

Ai Zheng. 2005 Oct;24(10):1252-6. Chinese.

PMID:
16219143
5.
6.

Phase I/II trial of vinorelbine and divided-dose carboplatin in advanced non-small cell lung cancer.

Masters GA, Hahn EA, Shevrin DH, Kies MS.

Lung Cancer. 2003 Feb;39(2):221-6.

PMID:
12581577
7.

Multicenter phase II trial of carboplatin/vinorelbine in elderly patients with advanced non-small-cell lung cancer efficacy and impact on quality of life: Groupe Francais de Pneumo-Cancerologie Study 9902.

LeCaer H, Delhoume JY, Thomas PA, Berard H, Paillotin D, Barriere JR, Gimenez C, Vergnenegre A, Muller P, Auquier P, Perol M.

Clin Lung Cancer. 2005 Sep;7(2):114-20.

PMID:
16179098
8.

Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).

Costa GJ, Fernandes AL, Pereira JR, Curtis JR, Santoro IL.

Lung Cancer. 2006 Aug;53(2):171-6. Epub 2006 Jun 6.

PMID:
16757059
9.

A phase I study of larotaxel (XRP9881) administered in combination with carboplatin in chemotherapy-naïve patients with stage IIIB or stage IV non-small cell lung cancer.

Robert F, Harper K, Ackerman J, Gupta S.

Cancer Chemother Pharmacol. 2010 Jan;65(2):227-34. doi: 10.1007/s00280-009-1026-5.

PMID:
19479255
10.

Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.

Paccagnella A, Favaretto A, Oniga F, Festi G, Lauro S, Morabito A, Ossana L, Sartore F, DePoli F, Fiorentino MV.

Cancer. 1996 Oct 15;78(8):1701-7.

11.

Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma.

Reck M, Macha HN, Del Barco S, Cornes P, Vaissière N, Morand M, Riggi M, Abratt R.

Lung Cancer. 2009 Jun;64(3):319-25. doi: 10.1016/j.lungcan.2008.10.014. Epub 2008 Dec 17.

PMID:
19095327
12.

Carboplatin and vinorelbine in untreated locally advanced and metastatic non-small cell lung cancer.

Horvath L, Boyer M, Clarke S, Beale P, Beith J, Underhill C, Stockler M, Bishop J.

Lung Cancer. 2001 May;32(2):173-8. Review.

PMID:
11325488
13.

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.

Paccagnella A, Favaretto A, Oniga F, Barbieri F, Ceresoli G, Torri W, Villa E, Verusio C, Cetto GL, Santo A, De Pangher V, Artioli F, Cacciani GC, Parodi G, Soresi F, Ghi MG, Morabito A, Biason R, Giusto M, Mosconi P, Chiarion Sileni V; GSTVP (Gruppo di Studio Tumori Polmonari del Veneto).

Lung Cancer. 2004 Jan;43(1):83-91.

PMID:
14698542
14.

Phase II study of carboplatin-paclitaxel combination chemotherapy in elderly patients with advanced non-small cell lung cancer.

Okamoto I, Moriyama E, Fujii S, Kishi H, Nomura M, Goto E, Kiyofuji C, Imamura F, Mori T, Matsumoto M.

Jpn J Clin Oncol. 2005 Apr;35(4):188-94. Review.

PMID:
15845567
15.

Mitomycin C, vinorelbine, carboplatin plus granulocyte-macrophage colony-stimulating factor for treatment of advanced non-small cell lung carcinoma.

Hejna M, Kornek GV, Raderer M, Marosi L, Schneeweiss B, Greul R, Weinländer G, Valencak J, Huber H, Scheithauer W.

Oncology. 1998 Nov-Dec;55(6):538-42.

PMID:
9778620
16.

Vinorelbine plus cisplatinum for the treatment of stage IIIB and IV non small cell lung carcinoma.

Gebbia V, Caruso M, Valenza R, Testa A, Cannata G, Verderame F, Cipolla C, Curto G, Oliveri D, Chiarenza M, et al.

Anticancer Res. 1994 May-Jun;14(3B):1247-9.

PMID:
8067691
17.

Accelerated split-course (type B) thoracic radiation therapy plus vinorelbine/carboplatin combination chemotherapy in stage III inoperable non-small cell lung cancer.

Iaffaioli RV, Caponigro F, Tortoriello A, Facchini G, Ravo V, Maccauro M, Dimitri P, Crovella F, Muto P.

Eur J Cancer. 1996 Oct;32A(11):1901-4.

PMID:
8943672
18.

Low dose carboplatin (AUC 4.5) combined with vinorelbine in the treatment of advanced non-small cell lung cancer: a single institution phase II study.

Bretti S, Manzin E, Celano A, Ritorto G, Loddo C, Berruti A.

Oncol Rep. 2001 Mar-Apr;8(2):381-5.

PMID:
11182060
19.

Paclitacxel and carboplatin in advanced non-small-cell lung cancer.

Huang PW, Gu YH, Lu KH, Shu YQ.

Biomed Pharmacother. 2006 Dec;60(10):698-700. Epub 2006 Oct 24.

PMID:
17071050
20.

Randomized phase II study of paclitaxel and carboplatin or vinorelbine in advanced non-small cell lung cancer.

Jahnke K, Keilholz U, Lüftner D, Thiel E, Schmittel A.

Anticancer Res. 2011 Jan;31(1):317-23.

PMID:
21273617

Supplemental Content

Support Center